■手术干预是脐尿管癌患者的首选治疗方法。由于并发症和减少开放手术的住院时间,微创方法是可取的。如今,机器人辅助手术越来越受欢迎,并且机器人辅助膀胱切除术可以在脐尿管癌患者中进行,并发症发生率低。
■我们进行了一项系统评价,以寻找评估接受机器人辅助手术治疗脐管癌的患者的研究。感兴趣的结果是膀胱切除术的类型,是否有脐带切除,总手术时间,控制台时间,术中并发症,估计失血量,术后并发症,住院时间,积极的手术切缘和记录的肿瘤复发的存在。
■在这项研究中,我们评估了3个队列,共21例患者.中位随访期为8至40个月。中等年龄在51到54岁之间,大多数(63.1%)是男性。一名患者(5.2%)接受了根治性膀胱切除术,19例患者(94.7%)接受膀胱部分切除术。所有病例均行脐带切除术,盆腔淋巴结清扫术14例(73.6%)。3例患者在术后中位数为17个月时复发,两例在套管针插入部位。此外,有一次死亡,这归因于术后心血管并发症。
■机器人辅助膀胱部分切除术在脐尿管癌患者中的不良结局发生率较低。对照研究,理想情况下是随机的,有必要建立机器人辅助膀胱切除术方法相对于开放手术的比较疗效和安全性。
UNASSIGNED: Surgical intervention is the treatment of choice in patients with urachal carcinoma. Due to complications and to reduce hospital stay from open surgery, minimally invasive approaches are desirable. Nowadays, robotic-assisted surgery has become increasingly popular, and robot-assisted cystectomy can be performed in patients with urachal carcinoma with low complication rates.
UNASSIGNED: We performed a systematic review to search for studies that evaluated patients who underwent robotic-assisted surgery for urachal carcinoma. The outcomes of interest were the type of cystectomy performed, whether there was umbilicus resection, total operative time, console time, intraoperative complications, estimated blood loss, postoperative complications, time of hospitalisation, positive surgical margins and the presence of documented tumour recurrence.
UNASSIGNED: In this study, we evaluated three cohorts comprising a total of 21 patients. The median follow-up period ranged from 8 to 40 months. Medium age was between 51 and 54 years, with a majority (63.1%) being male. One patient (5.2%) underwent a radical cystectomy, and 19 patients (94.7%) underwent to partial cystectomy. Umbilical resections were performed in all cases, and pelvic lymphadenectomy in 14 cases (73.6%). Recurrence occurred in three patients at a median of 17 months postoperation, two cases in the trocar insertion site. Additionally, there was one death, which was attributed to postoperative cardiovascular complications.
UNASSIGNED: Robotic-assisted partial cystectomy has a low incidence of adverse outcomes in patients with urachal carcinoma. Controlled studies, ideally randomised, are warranted to establish the comparative efficacy and safety of the robotic-assisted cystectomy approach relative to open surgery.